|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2009-3-27
|
|
pubmed:abstractText |
Recent studies of pemetrexed have identified a predictive role for non-small cell lung cancer (NSCLC) histology. We further reviewed the differential efficacy of pemetrexed according to histology in two large, phase III NSCLC trials.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1549-490X
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
253-63
|
|
pubmed:meshHeading |
pubmed-meshheading:19221167-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:19221167-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:19221167-Cisplatin,
pubmed-meshheading:19221167-Deoxycytidine,
pubmed-meshheading:19221167-Female,
pubmed-meshheading:19221167-Glutamates,
pubmed-meshheading:19221167-Guanine,
pubmed-meshheading:19221167-Humans,
pubmed-meshheading:19221167-Lung Neoplasms,
pubmed-meshheading:19221167-Male,
pubmed-meshheading:19221167-Middle Aged,
pubmed-meshheading:19221167-Randomized Controlled Trials as Topic,
pubmed-meshheading:19221167-Taxoids
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
The differential efficacy of pemetrexed according to NSCLC histology: a review of two Phase III studies.
|
|
pubmed:affiliation |
Thoracic Oncology Unit, University of Turin, San Luigi Hospital, Orbassano (Torino), Italy. giorgio.scagliotti@unito.it
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase III
|
